FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2536221331> ?p ?o ?g. }

• W2536221331 endingPage "471" @default.
• W2536221331 startingPage "464" @default.
• W2536221331 abstract "Abstract Purpose To evaluate changes of specific retinal imaging biomarkers [intraretinal hyper‐reflective retinal spots: HRS ; subfoveal neuroretinal detachment: SND ; and increased foveal autofluorescence: IFAF after intravitreal steroid or anti‐vascular endothelial growth factor treatment in diabetic macular oedema ( DME )] as possible indicators of retinal inflammatory condition. Methods Retrospective analysis of images and clinical charts of 49 eyes (49 patients) with DME treated with intravitreal dexamethasone (dexamethasone, 23 eyes) or intravitreal ranibizumab (ranibizumab, 26 eyes). All patients had fundus colour photograph, spectral domain optical coherence tomography (SD OCT) and fundus autofluorescence ( FAF ), best‐corrected visual acuity ( BCVA ) and microperimetry recorded before and 1 month after the end of treatment. Central macular thickness ( CMT ), number of HRS and presence of SND were evaluated by SD OCT . Fundus autofluorescence images were evaluated for area of ( IFAF ). Retinal sensitivity within 4° and 12° from fovea was quantified by microperimetry. Changes in morphologic and functional parameters were assessed, and correlation was performed by Pearson's correlation. Results Best‐corrected visual acuity and CMT improved in all patients, (p < 0.05, for both groups). Mean number of HRS decreased after both treatments (p < 0.0001). Subfoveal neuroretinal detachment resolved in 85.7% dexamethasone‐treated eyes (p = 0.014) and in 50% ranibizumab‐treated eyes (p = 0.025). Mean IFAF area decreased in both groups, (p < 0.0001, for both). A significantly higher decrease in CMT was observed in dexamethasone‐ versus ranibizumab‐treated eyes, (p = 0.032). In dexamethasone group, higher number of HRS at baseline and larger IFAF were correlated with higher increase in retinal sensitivity; eyes with SND at baseline had major decrease in CMT versus those without SND , (p = 0.003). Conclusion Higher number of HRS , larger area of IFAF and presence of SND may indicate a prevalent inflammatory condition in DME with specific response to targeted treatment." @default.
• W2536221331 created "2016-10-28" @default.
• W2536221331 creator A5038413562 @default.
• W2536221331 creator A5046783629 @default.
• W2536221331 creator A5048563371 @default.
• W2536221331 creator A5062231945 @default.
• W2536221331 creator A5062997260 @default.
• W2536221331 creator A5064231892 @default.
• W2536221331 creator A5064810373 @default.
• W2536221331 date "2016-10-24" @default.
• W2536221331 modified "2023-10-11" @default.
• W2536221331 title "Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema" @default.
• W2536221331 cites W1583152018 @default.
• W2536221331 cites W1909266145 @default.
• W2536221331 cites W1977604451 @default.
• W2536221331 cites W1981186191 @default.
• W2536221331 cites W1986366547 @default.
• W2536221331 cites W1994613531 @default.
• W2536221331 cites W1996703105 @default.
• W2536221331 cites W1999198957 @default.
• W2536221331 cites W1999846890 @default.
• W2536221331 cites W2005409914 @default.
• W2536221331 cites W2007155254 @default.
• W2536221331 cites W2012372812 @default.
• W2536221331 cites W2027474409 @default.
• W2536221331 cites W2031671233 @default.
• W2536221331 cites W2035817072 @default.
• W2536221331 cites W2037595837 @default.
• W2536221331 cites W2043808345 @default.
• W2536221331 cites W2044491468 @default.
• W2536221331 cites W2052023322 @default.
• W2536221331 cites W2058067541 @default.
• W2536221331 cites W2066516016 @default.
• W2536221331 cites W2070264842 @default.
• W2536221331 cites W2073453384 @default.
• W2536221331 cites W2087224371 @default.
• W2536221331 cites W2091534585 @default.
• W2536221331 cites W2094843683 @default.
• W2536221331 cites W2101319706 @default.
• W2536221331 cites W2121435502 @default.
• W2536221331 cites W2157997023 @default.
• W2536221331 cites W2227821591 @default.
• W2536221331 cites W2318537063 @default.
• W2536221331 cites W2322106283 @default.
• W2536221331 cites W67277669 @default.
• W2536221331 doi "https://doi.org/10.1111/aos.13294" @default.
• W2536221331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27775223" @default.
• W2536221331 hasPublicationYear "2016" @default.
• W2536221331 type Work @default.
• W2536221331 sameAs 2536221331 @default.
• W2536221331 citedByCount "99" @default.
• W2536221331 countsByYear W25362213312017 @default.
• W2536221331 countsByYear W25362213312018 @default.
• W2536221331 countsByYear W25362213312019 @default.
• W2536221331 countsByYear W25362213312020 @default.
• W2536221331 countsByYear W25362213312021 @default.
• W2536221331 countsByYear W25362213312022 @default.
• W2536221331 countsByYear W25362213312023 @default.
• W2536221331 crossrefType "journal-article" @default.
• W2536221331 hasAuthorship W2536221331A5038413562 @default.
• W2536221331 hasAuthorship W2536221331A5046783629 @default.
• W2536221331 hasAuthorship W2536221331A5048563371 @default.
• W2536221331 hasAuthorship W2536221331A5062231945 @default.
• W2536221331 hasAuthorship W2536221331A5062997260 @default.
• W2536221331 hasAuthorship W2536221331A5064231892 @default.
• W2536221331 hasAuthorship W2536221331A5064810373 @default.
• W2536221331 hasBestOaLocation W25362213311 @default.
• W2536221331 hasConcept C118487528 @default.
• W2536221331 hasConcept C126322002 @default.
• W2536221331 hasConcept C134018914 @default.
• W2536221331 hasConcept C141071460 @default.
• W2536221331 hasConcept C2776391266 @default.
• W2536221331 hasConcept C2776694085 @default.
• W2536221331 hasConcept C2777802072 @default.
• W2536221331 hasConcept C2778257484 @default.
• W2536221331 hasConcept C2778818243 @default.
• W2536221331 hasConcept C2779100554 @default.
• W2536221331 hasConcept C2779829184 @default.
• W2536221331 hasConcept C2780401358 @default.
• W2536221331 hasConcept C2780827179 @default.
• W2536221331 hasConcept C2781100027 @default.
• W2536221331 hasConcept C555293320 @default.
• W2536221331 hasConcept C71924100 @default.
• W2536221331 hasConceptScore W2536221331C118487528 @default.
• W2536221331 hasConceptScore W2536221331C126322002 @default.
• W2536221331 hasConceptScore W2536221331C134018914 @default.
• W2536221331 hasConceptScore W2536221331C141071460 @default.
• W2536221331 hasConceptScore W2536221331C2776391266 @default.
• W2536221331 hasConceptScore W2536221331C2776694085 @default.
• W2536221331 hasConceptScore W2536221331C2777802072 @default.
• W2536221331 hasConceptScore W2536221331C2778257484 @default.
• W2536221331 hasConceptScore W2536221331C2778818243 @default.
• W2536221331 hasConceptScore W2536221331C2779100554 @default.
• W2536221331 hasConceptScore W2536221331C2779829184 @default.
• W2536221331 hasConceptScore W2536221331C2780401358 @default.
• W2536221331 hasConceptScore W2536221331C2780827179 @default.
• W2536221331 hasConceptScore W2536221331C2781100027 @default.
• W2536221331 hasConceptScore W2536221331C555293320 @default.

• next